Sop's Arm

Genomenon Launches Curation On-Demand Service for Genetic Testing Labs

Retrieved on: 
Tuesday, December 5, 2023

ANN ARBOR, Mich., Dec. 5, 2023 /PRNewswire-PRWeb/ -- Genomenon, a leading genomic intelligence company, today announced the launch of Genomenon Curate-Pro, a rapid on-demand evidence curation and variant classification service for genetic testing labs. Genomenon Curate-Pro service leverages the company's automation and genetic curation expertise to address the laborious and expensive variant research and curation challenges faced by genomic scientists, empowering them to focus on variant interpretation and high-value patient-facing reporting.

Key Points: 
  • ANN ARBOR, Mich., Dec. 5, 2023 /PRNewswire-PRWeb/ -- Genomenon, a leading genomic intelligence company, today announced the launch of Genomenon Curate-Pro, a rapid on-demand evidence curation and variant classification service for genetic testing labs.
  • Genomenon Curate-Pro service leverages the company's automation and genetic curation expertise to address the laborious and expensive variant research and curation challenges faced by genomic scientists, empowering them to focus on variant interpretation and high-value patient-facing reporting.
  • Genomenon developed its high-speed genomic curation engine four years ago, with the ability to index the entirety of the genomic information buried in scientific publications.
  • "Genomenon Curate-Pro is a natural extension of Genomenon's vision of curating the genome – leveraging the company's genomic curation technology and human expertise to deliver an on-demand service to our clinical customers," explained Genomenon CEO, Mike Klein.

American Hardwood Floors Projects $600K Reduction of Detention & Demurrage Fees through Partnership with ITS Logistics

Retrieved on: 
Tuesday, May 30, 2023

RENO, Nev., May 30, 2023 (GLOBE NEWSWIRE) -- Family-owned hardwood flooring company American Hardwood Floors (AHF Products®) has been selling quality hardwood flooring for nearly a century.

Key Points: 
  • RENO, Nev., May 30, 2023 (GLOBE NEWSWIRE) -- Family-owned hardwood flooring company American Hardwood Floors (AHF Products®) has been selling quality hardwood flooring for nearly a century.
  • Following the disruptions of the pandemic, AHF partnered with ITS Logistics , enabling them to reduce accessorial fees by 40% per container in the first full month after the company lost about $1,000,000 on detention and demurrage in 2022.
  • “We needed assistance navigating through the new challenges brought on by the pandemic,” said Paul Polkinghorn, VP of Supply Chain for AHF Products®.
  • To read the entire case study and learn more about additional ways ITS was able to reduce accessorial fees and increase savings for AHF, visit ITS Logistics .

2 Day Recordkeeping and Documentation in a GLP Laboratory Online Course: US FDA, US EPA and OSHA Focus - October 27-28, 2022)

Retrieved on: 
Wednesday, October 5, 2022

DUBLIN, Oct. 5, 2022 /PRNewswire/ -- The "Recordkeeping and Documentation in a GLP Laboratory (US FDA, US EPA and OSHA Focus)" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 5, 2022 /PRNewswire/ -- The "Recordkeeping and Documentation in a GLP Laboratory (US FDA, US EPA and OSHA Focus)" training has been added to ResearchAndMarkets.com's offering.
  • The seminar covers both the general issues and many specifics that laboratories can receive a non-compliance on.
  • An auditor can find numerous common errors and many, many others that are specific to a particular laboratory.
  • This seminar will go through many of the compliance areas and point out some of both of these types.

2 Day Recordkeeping and Documentation in a GLP Laboratory Online Course: US FDA, US EPA and OSHA Focus - October 27-28, 2022 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 27, 2022

The "Recordkeeping and Documentation in a GLP Laboratory (US FDA, US EPA and OSHA Focus)" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Recordkeeping and Documentation in a GLP Laboratory (US FDA, US EPA and OSHA Focus)" training has been added to ResearchAndMarkets.com's offering.
  • The seminar covers both the general issues and many specifics that laboratories can receive a non-compliance on.
  • An auditor can find numerous common errors and many, many others that are specific to a particular laboratory.
  • This seminar will go through many of the compliance areas and point out some of both of these types.

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

Retrieved on: 
Monday, June 6, 2022

With experienced clinical teams in both regions, Novotech will share real-world success strategies for biotechs undertaking global clinical development programs."

Key Points: 
  • With experienced clinical teams in both regions, Novotech will share real-world success strategies for biotechs undertaking global clinical development programs."
  • According to Global Data whitepaper: EVOLUTION OF CLINICAL TRIALS IN THE ASIA PACIFIC REGION COMPARED TO THE US AND THE EU5*, over the past 5 years the growth of oncology trials (CAGR of 25%) in China outpaced other countries.
  • Novotech recently announced a partnership and investment in tech firm Prospection to support accelerated clinical trials with healthcare data analytics using real-world data.
  • Novotech is well positioned to serve biopharmaceutical clients conducting clinical trials in Asia and globally.

Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and Regulatory Strategy for China and US

Retrieved on: 
Thursday, June 2, 2022

The Novotech sponsored Summit sessions are:

Key Points: 
  • The Novotech sponsored Summit sessions are:
    China offers a compelling solution for expedited clinical trials especially in oncology with its vast patient populations and world-class KOLs.
  • - In addition, over the last five years more 70,000 new clinical trials were registered in the APAC region, the US, and the EU5.
  • Novotech recently announced a partnership and investment in tech firm Prospection to support accelerated clinical trials with healthcare data analytics using real-world data.
  • Novotech is well positioned to serve biopharmaceutical clients conducting clinical trials in Asia and globally.

Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials

Retrieved on: 
Wednesday, May 11, 2022

SYDNEY, May 12, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO China Summit 2022 event titled: Go/No Go Decisions Based on Early Phase Oncology Trials ('The Summit').

Key Points: 
  • SYDNEY, May 12, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO China Summit 2022 event titled: Go/No Go Decisions Based on Early Phase Oncology Trials ('The Summit').
  • The Summit will feature insights from leading Novotech experts tapping decades of oncology clinical experience in the APAC region.
  • Novotech, which has a reputation for delivering full-service, high-quality expedited clinical trials in Asia-Pacific, can now offer its biotech clients clinical services in the US to support later phase global studies.
  • Novotech is a CRO with integrated labs and phase I facilities providing drug development consulting and clinical development services.

Novotech Acquires US CRO NCGS, Expands Global Expertise

Retrieved on: 
Thursday, May 5, 2022

Novotech CEO Dr. John Moller said "We are very pleased to acquire such an impressive company with a strong history of quality and delivery in the United States.

Key Points: 
  • Novotech CEO Dr. John Moller said "We are very pleased to acquire such an impressive company with a strong history of quality and delivery in the United States.
  • The company's growth is a real credit to the knowledge and expertise of founder Nancy Snowden and the exceptional team she has formed.
  • "We have a similar cultural fit and focus on excellence, so joining Novotech will be seamless for both ours and Novotech's clients.
  • Novotech and NCGS have a collaboration history of over a decade which will also support the seamless integration," said Snowden.

ProPharma Group Announces the Acquisition of M Squared Associates

Retrieved on: 
Wednesday, March 16, 2022

OVERLAND PARK , Kan., March 16, 2022 /PRNewswire-PRWeb/ --ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the acquisition of M Squared Associates (M2), an industry leading clinical, regulatory and quality consulting firm serving the medical device and diagnostic industry.

Key Points: 
  • OVERLAND PARK , Kan., March 16, 2022 /PRNewswire-PRWeb/ --ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the acquisition of M Squared Associates (M2), an industry leading clinical, regulatory and quality consulting firm serving the medical device and diagnostic industry.
  • "This acquisition is a pivotal move that will positively impact our combined client base to provide full end-to-end support for getting medical devices, combination products and diagnostics to market," said Michael Stomberg, CEO of ProPharma Group.
  • ProPharma Group is the global, independent, single-source provider of regulatory, clinical and compliance services serving pharmaceutical, biotechnology, and medical device companies.
  • Founded in 2001, ProPharma Group has more than 2500 colleagues worldwide providing solutions to complex challenges in a dynamic regulatory environment.

Optimi Health Engages Expert Management Consultancy to Drive Corporate Visibility

Retrieved on: 
Wednesday, November 3, 2021

Kydder Group is currently spearheading Canadas first Memorandum of Regulatory Approval (MORA) to amend current Health Canada regulations, hopefully resulting in controlled legal access to psilocybin therapy for palliative and end-of-life Canadians.

Key Points: 
  • Kydder Group is currently spearheading Canadas first Memorandum of Regulatory Approval (MORA) to amend current Health Canada regulations, hopefully resulting in controlled legal access to psilocybin therapy for palliative and end-of-life Canadians.
  • Overall, consumer and regulatory-facing efforts will be coordinated with Optimi Healths communications providers to assist in the management of messaging strategy and tactics.
  • On Behalf of the Board of Directors,
    Optimi is developing a sophisticated mushroom brand that focuses on the health and wellness markets.
  • Optimi is committed to expert cultivation and quality production subject to and in accordance with the terms of all applicable laws and governing regulations to ensure safe, superior Canadian fungi production.